Age (Years) | 48 | 65 | <0.001 |
BMI (kg/m2) | 22 | 26 | 0.002 |
Developed ALI - n (%) | 6 (43) | 6 (16) | 0.045 |
Developed respiratory infection - n (%) | 5 (35) | 12 (32) | 0.824 |
EVLWI (ml/kg) | Pre-op | 8.3 | 7.8 | 0.520 |
Post-op | 11.0 | 9.3 | 0.191 |
Day 1 | 9.8 | 7.9 | 0.040 |
PVPI | Pre-op | 2.13 | 1.74 | 0.151 |
Post-op | 2.43 | 1.97 | 0.050 |
Day 1 | 2.09 | 1.69 | 0.008 |
Fas Ligand(pg/ml) | Pre-op | 21.85 | 36.78 | 0.001 |
Post-op | 17.62 | 30.73 | 0.001 |
Day 1 | 9.05 | 18.38 | <0.001 |
sICAM-1 (ng/ml) | Pre-op | 103.52 | 56.95 | 0.005 |
Post-op | 51.38 | 43.01 | 0.199 |
Day 1 | 100.38 | 88.00 | 0.226 |
IL-17A (pg/ml) | Pre-op | 8.42 | 55.66 | 0.088 |
Post-op | 2.64 | 36.84 | 0.043 |
Day 1 | 8.26 | 83.57 | 0.084 |
VEGF (pg/ml) | BAL | 94.05 | 153.40 | 0.016 |
IL1ra (pg/ml) | BAL | 50.99 | 9.83 | 0.007 |
sTNFR1 (pg/ml) | BAL | 270.5 | 168.5 | 0.042 |